ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2

被引:13
|
作者
Chang, D. L. F.
Qiu, W.
Ying, H.
Zhang, Y.
Chen, C-Y
Xiao, Z-X J.
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Med, Grad Program Mol Med, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
基金
美国国家卫生研究院;
关键词
ARF; retinoblastoma protein; MDM2; cell; cycle; cancer;
D O I
10.1038/sj.onc.1210254
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The INK4a/ARF locus, encoding two tumor suppressor proteins, p16(INK4a) and p14(ARF) (ARF), plays key roles in many cellular processes including cell proliferation, apoptosis, cellular senescence and differentiation. Inactivation of INK4a/ARF is one of the most frequent events during human cancer development. Although p16(INK4a) is a critical component in retinoblastoma protein (Rb)-mediated growth regulatory pathway, p14ARF plays a pivotal role in the activation of p53 upon oncogenic stress signals. A body of evidence indicates that ARF also possesses growth suppression functions independent of p53, the mechanism of which is not well understood. We have recently shown that MDM2 interacts with Rb and promotes proteasome-dependent Rb degradation. In this study, we show that ARF disrupts MDM2 -Rb interaction resulting in Rb accumulation. Wild-type ARF, but not ARF mutant defective in MDM2 interaction, stabilizes Rb and inhibits colony foci formation independent of p53. In addition, ablation of Rb impairs ARF function in growth suppression. Thus, this study demonstrates that ARF plays a direct role in regulation of Rb and suggests that inactivation of ARF may lead to defects in both p53 and Rb pathways in human cancer development.
引用
收藏
页码:4627 / 4634
页数:8
相关论文
共 50 条
  • [1] ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2
    D L F Chang
    W Qiu
    H Ying
    Y Zhang
    C-Y Chen
    Z-X J Xiao
    [J]. Oncogene, 2007, 26 : 4627 - 4634
  • [2] Retinoblastoma and protein expression of P14ARF, MDM2 and P53
    Carvalho, L. M.
    Alarcao, A. M.
    Teixeira, C. L.
    Fonseca, M. C.
    Proenca, R. D.
    [J]. HISTOPATHOLOGY, 2010, 57 : 210 - 210
  • [3] Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma
    Guo, Ying
    Pajovic, Sanja
    Gallie, Brenda L.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 375 (01) : 1 - 5
  • [4] INTERACTION BETWEEN THE RETINOBLASTOMA PROTEIN AND THE ONCOPROTEIN MDM2
    XIAO, ZX
    CHEN, JD
    LEVINE, AJ
    MODJTAHEDI, N
    XING, J
    SELLERS, WR
    LIVINGSTON, DM
    [J]. NATURE, 1995, 375 (6533) : 694 - 698
  • [5] P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2
    Xirodimas, DP
    Chisholm, J
    Desterro, JMS
    Lane, DP
    Hay, RT
    [J]. FEBS LETTERS, 2002, 528 (1-3) : 207 - 211
  • [6] MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein
    Sdek, P
    Ying, HQ
    Chang, DLF
    Qiu, W
    Zheng, HW
    Touitou, R
    Allday, MJ
    Xiao, ZXJ
    [J]. MOLECULAR CELL, 2005, 20 (05) : 699 - 708
  • [7] Targeting MDM2 and MDMX in retinoblastoma
    Laurie, Nikia A.
    Schin-Shih, Chie
    Dyer, Michael A.
    [J]. CURRENT CANCER DRUG TARGETS, 2007, 7 (07) : 689 - 695
  • [8] MDM2 as a Modifier Gene in Retinoblastoma
    Castera, Laurent
    Sabbagh, Audrey
    Dehainault, Catherine
    Michaux, Dorothee
    Mansuet-Lupo, Audrey
    Patillon, Blandine
    Lamar, Estelle
    Aerts, Isabelle
    Lumbroso-Le Rouic, Livia
    Couturier, Jerome
    Stoppa-Lyonnet, Dominique
    Gauthier-Villars, Marion
    Houdayer, Claude
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (23) : 1805 - 1808
  • [9] MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
    D-L Qi
    D Cobrinik
    [J]. Oncogene, 2017, 36 : 1760 - 1769
  • [10] MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
    Qi, D-L
    Cobrinik, D.
    [J]. ONCOGENE, 2017, 36 (13) : 1760 - 1769